Schizophrenia, depression, and bipolar disorder have more in common than previously thought. They are not only linked through shared genes but also the genetic mutations associated with them work together to govern immunity, brain signaling, and genome function later in life.
A study shows the genetic overlap between psychiatric disorders leads to meaningful paths for treatment. According to the CDCP, it was found that approximately 50 percent of adults in the US will develop a mental illness in their lifetime, Schizophrenia, bipolar disorder, depression will 1%, 4%, 17% of adults in the US, respectively, over the course of their life — and these disorders can be costly to treat.
Most people diagnosed with mental illness are either poorly treated or untreated, according to a study of US mental health services published in the Journal of the AMA. Overall, the cost of mental illness in the US amounts to $300 billion a year for treatment, lost wages, and disability benefits. Drug discovery for many of these disorders has essentially stalled out; today's finding may lead to new approaches that could ultimately benefit patients.
Source: The Verge